Abivax hosted a virtual KOL event as webcast on Tuesday, April 20, 2021 at 1:30 pm CEST (7:30 am EDT), ahead of the data read-out of its ABX464 phase 2b clinical study in UC. Prof. Bruce Sands, M.D., M.S., Chief of the Division of Gastroenterology at the Mount Sinai School of Medicine in New York City, NY, provided expert information on existing and future treatment options for UC, including current unmet medical needs. In addition, Abivax will provided an update on the safety and efficacy of ABX464 as it applies to UC.

The replay of the webcast is available at https://media.rampard.com/20210420/